NextCure, Inc. (NXTC)
5.33
+0.21
(+4.10%)
USD |
NASDAQ |
Nov 06, 16:00
5.54
+0.21
(+3.94%)
After-Hours: 20:00
NextCure Price : 5.33 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 5.415 | 5.71 | 5.10 | 5.33 | 49878.00 |
| Nov 05, 2026 | 5.545 | 5.59 | 5.10 | 5.12 | 24126.00 |
| Nov 04, 2026 | 6.01 | 6.435 | 5.41 | 5.85 | 39414.00 |
| Nov 03, 2026 | 5.71 | 6.04 | 5.60 | 5.91 | 33363.00 |
| Nov 02, 2026 | 6.41 | 6.51 | 5.33 | 5.695 | 64063.00 |
| Oct 30, 2026 | 6.33 | 6.58 | 6.21 | 6.31 | 19199.00 |
| Oct 29, 2026 | 6.06 | 6.66 | 5.844 | 6.525 | 58258.00 |
| Oct 28, 2026 | 5.72 | 6.41 | 5.581 | 6.34 | 64545.00 |
| Oct 27, 2026 | 5.305 | 5.785 | 4.86 | 5.715 | 142088.0 |
| Oct 26, 2026 | 4.91 | 5.48 | 4.776 | 5.225 | 25400.00 |
| Oct 23, 2026 | 4.96 | 5.28 | 4.529 | 4.98 | 48546.00 |
| Oct 22, 2026 | 5.28 | 5.85 | 4.61 | 4.72 | 71134.00 |
| Oct 21, 2026 | 5.51 | 6.042 | 5.25 | 5.415 | 71520.00 |
| Oct 20, 2026 | 5.87 | 6.10 | 5.326 | 5.44 | 82116.00 |
| Oct 19, 2026 | 6.16 | 6.46 | 5.45 | 5.67 | 67290.00 |
| Oct 16, 2026 | 6.615 | 6.66 | 6.08 | 6.24 | 39047.00 |
| Oct 15, 2026 | 6.593 | 7.22 | 6.593 | 6.88 | 72423.00 |
| Oct 14, 2026 | 6.16 | 6.858 | 6.11 | 6.58 | 51643.00 |
| Oct 13, 2026 | 6.58 | 6.80 | 6.21 | 6.28 | 54706.00 |
| Oct 12, 2026 | 7.08 | 7.52 | 6.03 | 6.64 | 130472.0 |
| Oct 09, 2026 | 6.675 | 7.20 | 6.30 | 7.18 | 85746.00 |
| Oct 08, 2026 | 6.24 | 6.94 | 6.048 | 6.78 | 82602.00 |
| Oct 07, 2026 | 5.70 | 6.72 | 5.42 | 6.56 | 109568.0 |
| Oct 06, 2026 | 5.01 | 5.905 | 5.00 | 5.685 | 122586.0 |
| Oct 05, 2026 | 5.05 | 5.19 | 4.94 | 5.05 | 14554.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 58.16 |
| Oncolytics Biotech, Inc. | 0.4394 |
| Sangamo Therapeutics, Inc. | 0.114 |
| Sarepta Therapeutics, Inc. | 17.82 |
| Anixa Biosciences, Inc. | 3.175 |
Price Related Metrics
| Price to Book Value | 1.785 |
| Earnings Yield | -198.7% |
| Market Cap | 21.69M |